SCHEMBL7200151

SCHEMBL7200151

Cc1nn(C)c(OC(=O)Cc2ccccc2)c1C(=O)c1ccc(Cl)cc1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.42
KDM4E B2RXH2 1/20 0.42
SMN1; SMN2 Q16637 5/20 0.41
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
HTT P42858 2/20 0.41
NR2F2 P24468 1/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
TP53 P04637 1/20 0.40
HSD17B10 Q99714 1/20 0.40
ABCB1 P08183 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2C19 P33261 2/20 0.38
CYP2D6 P10635 1/20 0.38
NTRK1 P04629 1/20 0.38
LMNA P02545 2/20 0.38
POLB P06746 1/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10753763 0.94 MAPT (0.44) MAPTKDM4ESMN1; SMN2KMT2AMEN1
SCHEMBL10981678 0.90 MAPT (0.41) MAPTKDM4ESMN1; SMN2KMT2AMEN1
SCHEMBL11117488 0.86 NPC1 (0.47) MAPTKDM4ESMN1; SMN2KMT2AMEN1
SCHEMBL10755866 0.86 KMT2A (0.45) MAPTKDM4ESMN1; SMN2KMT2AMEN1
SCHEMBL10751811 0.86 MAPT (0.45) MAPTKDM4ESMN1; SMN2KMT2AMEN1
SCHEMBL10751205 0.86 SMN1; SMN2 (0.45) MAPTKDM4ESMN1; SMN2KMT2AMEN1
Chlorobenzene SCHEMBL10753772 0.84 MAPT (0.47) MAPTKDM4ESMN1; SMN2KMT2AMEN1
SCHEMBL10749743 0.84 MAPT (0.47) MAPTKDM4ESMN1; SMN2KMT2AMEN1
SCHEMBL10752620 0.84 KMT2A (0.48) MAPTKDM4ESMN1; SMN2KMT2AMEN1
SCHEMBL10752114 0.83 MAPT (0.46) MAPTKDM4ESMN1; SMN2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4261729-A Herbicidal compositions and pyrazole derivatives SANKYO COMPANY LIMITED (JP) 1981-04-14 US claimed
US-20030191025-A1 Herbicidal compositions with substituted phenylsulfonylureas for controlling weeds in rice BAYER INTELLECTUAL PROPERTY GMBH (DE) 2003-10-09 US disclosed
US-4687858-A HERBICIDES SANKYO COMPANY LIMITED (JP) 1987-08-18 US disclosed
US-4508910-A Herbicidal 4-benzoyl-5-hydroxy-pyrazales SANKYO COMPANY LTD. (JP) 1985-04-02 US disclosed
US-4414392-A Herbicidal compositions and pyrazole derivatives SANKYO COMPANY, LTD. (JP) 1983-11-08 US disclosed
US-4301293-A Herbicidal compositions and pyrazole derivatives SANKYO COMPANY LTD. (JP) 1981-11-17 US disclosed
US-4146726-A HERBICIDES SANKYO COMPANY LIMITED (JP) 1979-03-27 US disclosed
US-4063925-A Herbicidal compositions SANKYO COMPANY LIMITED (JA) 1977-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030191025-A1 Herbicidal compositions with substituted phenylsulfonylureas for controlling weeds in rice DDT, CYCS, CBR3 MAPT 4704/4885KDM4E 235/4885SMN1; SMN2 2949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.